This act establishes the Web of Biological Data, a national platform managed by a National Laboratory to accelerate biological research through centralized, secure access to federally funded data and advanced data science tools.
Matt Van Epps
Representative
TN-7
The Web of Biological Data Act of 2026 establishes a national platform, managed by a Department of Energy-funded National Laboratory, to centralize and accelerate biological research using AI and data science. This platform will serve as a single entry point for accessing federally funded biological data, incorporating robust quality metrics and tiered cybersecurity. The bill mandates a phased rollout, beginning with a pilot version within two years and expanding to full researcher access within five years, while strictly protecting data privacy and existing use limitations.
New $470 Million 'Web of Biological Data' to Fuel AI-Driven Medical Breakthroughs by 2031
The Web of Biological Data Act of 2026 is a massive digital infrastructure project designed to turn the U.S. into a powerhouse for biotech innovation. Think of it as a high-tech library for life itself—a centralized, searchable platform that gathers biological data from across the country so researchers can use Artificial Intelligence to solve complex medical puzzles. Managed by a National Laboratory, this 'Web' will serve as a one-stop shop for scientists to access everything from DNA sequences to protein structures, with a clear goal: speeding up the time it takes to go from a lab discovery to a life-saving treatment at your local pharmacy.
The Blueprint for a Bio-Brain
This isn't just a basic website; it's a multi-year rollout backed by $470 million in funding. Within 180 days, the Department of Energy will pick a National Laboratory to lead the charge. By year two, they’ll launch a pilot version focusing on specific data types, and by year five, the system will be open to all U.S. researchers. For a scientist working at a small startup or a university, this means no more hunting through dozens of fragmented databases to find the information they need to test a new cancer drug. Instead, they’ll have a single entry point with standard data formats that are ready-made for AI training, potentially cutting years off the research cycle.
Security and the 'No-Access' List
When you’re dealing with biological data, security is the name of the game. Section 2 of the bill requires 'tiered cybersecurity' to protect sensitive info and mandates an independent security audit every two years to catch leaks before they happen. There’s also a heavy focus on keeping this data in the right hands. The Secretary of Energy has the power to block access to 'adversarial nations' or countries that don’t share their own data in return. While this protects American intellectual property, it does put a lot of trust in the Secretary to decide who is on the 'naughty list' without much outside oversight.
Who’s Steering the Ship?
The bill creates an 11-member advisory board—mostly experts from industry, academia, and government—to oversee the project. Interestingly, this board is exempt from the Federal Advisory Committee Act, which usually requires meetings to be public and transparent. This might help the group move faster, but it also means the public won't always have a seat at the table to see how decisions are being made. For the average person, the benefit here is the promise of faster medical progress, but the trade-off is a system that operates with a bit less public visibility than your typical government project. However, the bill explicitly states that existing privacy laws and patient consent rules remain in full force, ensuring your personal health info isn't just tossed into the mix without protection.